Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LQDA · against 588 other Healthcare companies listed in US-listed
Ranked #132 of 589 · scores higher than 77% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including LQDA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | LQDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 3.3% | -4.3% | 81% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 4.6% | -0.8% | 69% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 3.9% | -2.3% | 76% | 20% | |
| Book yieldHigher is better · 587 reported | 5.2% | 25.9% | 18% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 132 | 838M USD | 59 | 33 | |
| 132 | 35.0B USD | 59 | 52 | |
| 132 | 4.3B USD | 59 | 54 | |
| 132 | 1.8B USD | 59 | 79 | |
| 132 | 3.8B USD | 59 | 71 | |
| 132 | 119.1B USD | 59 | 57 | |
| 132 | 5.3B USD | 59 | 63 | |
| 139 | 58.6B USD | 58 | 52 | |
| 139 | 641.4B USD | 58 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score